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Edited by Noboru MizushimaAbstract Caloric restriction (CR) is known to promote longev-
ity in various species. Sirtuin-mediated deacetylation has been
shown to be related to the promotion of longevity in some spe-
cies. Here, we show that CR of rats led to an increase in the level
of Werner syndrome protein (WRN), a recognized DNA repair
protein. In addition, CR simultaneously increased the level of
SIRT1, a mammalian sirtuin. In HEK293T cells, sirtuin inhibi-
tors decreased the WRN level, and this eﬀect was suppressed by
proteasomal inhibitors. Furthermore, we found a decrease in the
WRN level in Sirt1-deﬁcient mice. These results indicate that
sirtuin-mediated deacetylation stabilizes WRN.
Structured summary:
MINT-6603869:
ubiquitin (uniprotkb:P62988) physically interacts (MI:0218)
with WRN (uniprotkb:Q14191) by pull down (MI:0096)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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restriction1. Introduction
Proteins undergo many kinds of posttranslational modiﬁca-
tions, and these are known to modulate enzymatic activity and
changes in localization and regulate protein–protein interac-
tions. In our previous studies, we examined the sumoylation
[1], ubiquitination [2], polyglutamylation [3,4], and phosphor-
ylation [5] of proteins as posttranslational modiﬁcations. In the
current study, we focused on sirtuins—nicotinamide adenine
dinucleotide (NAD)-dependent deacetylases that have been
linked to aging biology. Sirtuins diﬀer from the ligases and ki-
nases described in our previous reports because they require
NAD for reactions. The analysis of sirtuins is expected to pro-
vide knowledge on aging from another perspective.
Sirtuins, including yeast silent information regulator 2 (Sir2)
and its orthologs, have been shown to exhibit NAD-dependent
histone deacetylase (type III HDAC) activity in an in vitro*Corresponding author. Address: Hamamatsu University School of
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doi:10.1016/j.febslet.2008.06.031deacetylation assay [6]. Small-molecule activators and inhibi-
tors of sirtuins have been characterized [7]. Sirtuin activators
are known to increase the lifespan of Saccharomyces cerevisiae
[8], Caenorhabditis elegans, and Drosophila melanogaster [9],
when the Sir2 enzyme is functional.
SIRT1 is the closest mammalian ortholog of yeast Sir2 [10].
It is known to target some substrates besides histones for
deacetylation, such as the tumor suppressor p53 [11,12]. In
mammalian cells, SIRT1 regulates apoptosis in response to
some stresses. Sirt1-knockout mice have been generated and
reported by two diﬀerent groups, and the commonly recog-
nized phenotypes in these mice are small body size and a high
percentage of embryonic or postnatal lethality [13,14].
Some genetic defects in the DNA repair pathways, including
DNA metabolism, have been linked to premature aging-like
features in the mouse [15]. Moreover, in humans, several prog-
eroid syndromes such as Werner syndrome are related to ge-
netic defects in the DNA repair system [16]. Molecular
defects in the DNA repair pathways have been suggested to
cause genomic instability and premature aging-like symptoms,
although some of these symptoms are considered to reﬂect
normal aging [17].
Considering this background, we focused on the molecular
connections between sirtuin-mediated deacetylation and
DNA repair in order to study longevity and premature aging.
In this paper, we show that sirtuin-mediated deacetylation sta-
bilizes WRN. Our ﬁndings will help understand the contribu-
tion of sirtuin deacetylase activity to longevity.2. Materials and methods
2.1. Animals
All procedures related to the care and treatment of animals were in
accordance with the institutional guidelines and those lay down by the
National Institute of Health and the Animal Care and Use Committee
(Mitsubishi Kagaku Institute of Life Sciences). Caloric restriction of
rats and tissue extraction were performed at the Material Research
Center (Tokyo, Japan). Detailed information on food intake and body
weight is provided in Fig. S1. Sirt1-heterozygous mice, designated
Sirt1+/D, were generated in a previous study [13], and homozygous mu-
tant oﬀspring (Sirt1D/D) from heterozygous parents were generated by
in vitro fertilization and embryo transfer (IVF-ET).2.2. Western blot analysis
Liver tissue was homogenized in a mixture of 20 mM Hepes (pH
8.0), 150 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 1% Triton X-100,blished by Elsevier B.V. All rights reserved.
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then centrifuged at 20000 · g for 10 min. The soluble fraction was
added to sodium dodecyl sulfate (SDS) sample buﬀer. For harvesting
the cultured cells, the samples were washed with PBS (–) and lysed with
SDS sample buﬀer. The resulting samples (10 lg of protein) were used
for immunoblot analysis.
2.3. RT-PCR analysis
Liver tissue from animals and culture cells were homogenized in Sep-
asol-RNA I Super (Nacalai Tesque, Kyoto, Japan), and total RNA
was isolated and reverse transcribed with ReverTra Ace (TOYOBO,
Tokyo, Japan). Real-time PCR was conducted by ABI PRISM7900
Sequence Detection System (Applied Biosystems, Foster City, CA,
USA), using Power SYBR Green PCR Master Mix (Applied Biosys-
tems) and gene-speciﬁc primers. Each data point in individual experi-
ments was calculated from the mean of triplicate determinations.
Conventional PCR was performed with AmpliTaq Gold polymerase
(Applied Biosystems) in Fig. 4. Primer sequences are provided in the
Supplemental methods section.
2.4. Cell culture and drug treatment
Human embryonic kidney (HEK293T) cells were cultured at 37 C
in air with 10% CO2. Dulbeccos modiﬁed Eagles medium (DMEM;
Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum (FBS; HyClone, Logan, UT, USA) was used for the culture.
Cells were treated with sirtinol (Sigma, St. Louis, MO, USA). Cyclo-
heximide (Sigma), trichostatin A (Sigma), epoxomicin (Peptide Insti-
tute, Osaka Japan), and MG132 (Peptide Institute) were also used in
the assay.
2.5. Aﬃnity puriﬁcation
His-ubiquitin was overexpressed in HEK293T cells, and puriﬁed
using TALON aﬃnity resin (Clontech, Mountain View, CA, USA) fol-
lowing lysis of the cells with phosphate buﬀer (0.1 M sodium phos-
phate buﬀer [pH 7.4], 0.3 M NaCl and 10 mM imidazole) containing
6 M guanidine hydrochloride. The resins were washed three times with
phosphate buﬀer containing 8 M urea, and then the ﬁnal wash was car-
ried out with phosphate buﬀer.3. Results
3.1. Increase in liver WRN content of calorie-restricted rats
In order to determine the association between sirtuins and
DNA repair, we used the technique of caloric restriction
(CR), which is an eﬀective intervention for increasing the life-
span in the case of many diﬀerent organisms [18]. It has been
reported that the eﬀect of CR is mediated by sirtuins in some
organisms [19,20]. This implies that the level of a SIRT1-asso-
ciated protein ﬂuctuates in calorie-restricted animals. On the
other hand, CR was found to increase in vivo DNA repair,
as reported in an unscheduled DNA synthesis (UDS) assayWRN
SIRT1
GAPDH
AL CR
100  105  116    69     68    69Food
intake (%)
TOPO I
W
R
N
 p
ro
te
in
 le
ve
l
Fig. 1. Caloric restriction induces an increase in the WRN protein levels in th
the left panels along with the relative amount of food intake. The graph on t
the Western blot signal intensities. (B) Real-time RT-PCR was performed for
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outliers, which were also used to calculate the median values. AL: n = 6; CR[21]. Recently, Lis group reported that acetylated WRN exhib-
its low helicase and exonuclease activities and that SIRT1 can
reverse this suppression of WRN activity via deacetylation
[22]. Since the correlation between the dynamics of WRN
and the deacetylase activity of sirtuin remains unclear, we
examined the WRN protein levels in calorie-restricted rats
(Figs. 1A and S1). The SIRT1 level in the livers of the calo-
rie-restricted rats increased, as reported previously [23]. Nota-
bly, the WRN protein levels were also signiﬁcantly increased,
while those of topoisomerase I (TOPO I), which is known to
interact with WRN [24], were not (Fig. 1A). Interestingly,
the transcription of WRN mRNA was not observed to be in-
creased in the calorie-restricted rats (Fig. 1B). These results
show that CR posttranscriptionally increases WRN expression
in animals.
3.2. Decrease in the WRN level in the HEK293T human culture
cell line by SIRT1 deacetylase inhibitor
We next aimed to determine whether the increase in the
WRN protein levels depended on sirtuin deacetylase activity.
Sirtinol and trichostatin A (TSA) have been characterized as
a sirtuin deacetylase inhibitor [25] and a type I and II HDAC
inhibitor [26], respectively. Notably, treatment with sirtinol
eﬃciently led to a reduction in the WRN level, while treatment
with TSA did not (Fig. 2A), indicating that sirtuins speciﬁcally
regulate the WRN protein levels. As a control, we showed that
these two inhibitors induced p53 acetylation, which is consis-
tent with the known eﬀect of both types of inhibitors in the
regulation of p53 acetylation [11]. WRN regulation appears
to be posttranscriptional, as indicated by the real-time RT-
PCR analysis data presented in Fig. 1B. Therefore, we decided
to examine the possibility that WRN is regulated through sta-
bilization of the protein levels. For this purpose, cycloheximide
(CHX), a translational inhibitor, was used (Fig. 2B). The half
life of WRN decreased in the cells treated with sirtinol (sirtinol
+: 4.3 h) compared with the control (sirtinol : more than 8 h).
On the other hand, a decreased mRNA level of WRN was not
observed at least in the sample treated with sirtinol for 4 h
(Fig. 2C). These results indicate that sirtuin-mediated deacety-
lation is important for the stabilization of WRN protein.
3.3. Degradation of WRN through the 26S proteasome in
presence of an SIRT1 deacetylase inhibitor
As indicated above, the dynamics of WRN protein is regu-
lated posttranslationally. Therefore, we analyzed the eﬀect of
proteasome inhibitors on the levels of the WRN protein. The0
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Fig. 2. Level of WRN decreases in cultured cells in the presence of a SIRT1 deacetylase inhibitor. (A) HEK293T cells were incubated with sirtinol or
TSA at the indicated concentrations for 20 h. TOPO I served as a loading control. (B) HEK293T cells were treated with cycloheximide (30 lg/ml), a
translational inhibitor, for the indicated time in presence or absence of sirtinol (100 lM). (C) Real-time RT-PCR was performed for a comparative
analysis of WRN mRNA level in presence of sirtinol. The graphs represent the average values, and approximation curves are shown. Error
bar = S.E.M. (n = 3).
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proteins [27]. As shown in Fig. 3A, the sirtinol-induced de-
crease in the WRN level was suppressed by epoxomicin or
MG132, both of which are speciﬁc proteasome inhibitors.
Next, we performed aﬃnity puriﬁcation to His-ubiquitin-
tagged proteins (Fig. 3B). Ubiquitinated WRN, detected in
the high molecular region of SDS–polyacrylamide gel, was
accumulated by the co-treatment of sirtinol and MG132. These
results indicate that the 26S proteasome degraded WRN
through the ubiquitin pathway when the sirtuin deacetylase
activity was suppressed.
3.4. Decrease in the WRN level in the liver of Sirt1D/D mice
The results in Fig. 2 suggests the possibility that a defect in
one of the sirtuins leads to decrease in the protein level of
WRN. Since SIRT1 is the closest mammalian ortholog of yeast0
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Fig. 3. WRN is degraded through the 26S proteasome in presence of
an SIRT1 deacetylase inhibitor. (A) HEK293T cells were treated with
epoxomicin (1 lM, 14 h) and MG132 (5 lM, 14 h), both proteasome
inhibitors, in the presence of sirtinol (100 lM, 20 h). The graph
represents the average values. Error bar = S.E.M. (n = 3). (B) His-
ubiquitin was expressed in the cells in presence of sirtinol (100 lM, 8 h)
or MG132 (5 lM, 8 h). After aﬃnity puriﬁcation of His-ubiquitin-
tagged proteins, they were analyzed by Western blot analysis with anti-
WRN antibody.Sir2, we analyzed the dynamics of WRN in Sirt1D/D mice. The
WRN level in the liver was lower in Sirt1D/D mice than in
Sirt1+/+ mice (Fig. 4). This decrease appears to have occurred
posttranscriptionally, because the RT-PCR analysis did not
show a diﬀerence in the WRN mRNA signals between the
Sirt1D/D and Sirt1+/+ mice (Fig. 4).4. Discussion
In this study, we showed that the sirtuin deacetylation path-
way stabilizes WRN. Defects in functional sirtuin led to a de-
crease in the WRN level (Fig. 2A), and this decrease was
suppressed by proteasome inhibitors (Fig. 3A). Our results
suggest that sirtuin deacetylase activity protects WRN from
ubiquitination and sequential degradation by the 26S protea-
some. Recently, it has been reported that the acetylation of
WRN suppresses its helicase and exonuclease activities and
that SIRT1 catalyzes the deacetylation of WRN [22]. These
ﬁndings seem to be consistent with our results: both indicate
that sirtuin positively regulates WRN function. Lis report
showed that SIRT1 also mediates the re-entry of WRN into
the nucleolus following DNA damage. Therefore, the instabil-
ity of WRN demonstrated in our study may result from a delay
in the translocation of WRN to the nucleolus in the absence of
functional SIRT1. It seems that it is unnecessary for acetylated
WRN, which is probably incompetent, to predominantly
remain in the nucleoplasm, where various DNA repair and
metabolic processes are underway; therefore, ineﬃcient
WRN needs to be degraded to ensure that there is no prejudi-
cial activity. Otherwise, SIRT1 may degrade WRN irrespective
of its localization and deacetylation. WRN could be ubiquiti-
nated by a ubiquitin ligase that is deacetylated by SIRT1.
The identiﬁcation and characterization of such putative ubiq-
uitin ligases will be the focus of future studies.
Quantitative analysis showed that the mRNA level of WRN
was not diﬀerence between the cells treated with sirtinol for 0
and 4 h (Fig. 2C). Because the half life of WRN protein was
4.3 h in presence of sirtinol (Fig. 2B), posttranslational
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Fig. 4. WRN protein level is decreased in the livers of Sirt1D/Dmice. Representative results of Western blot and RT-PCR are shown in the left panels.
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2482 T. Kahyo et al. / FEBS Letters 582 (2008) 2479–2483regulation should dominantly aﬀect the dynamics of WRN at
least for that period. On the other hand, the mRNA level of
WRN decreased in the cells treated with sirtinol for 8 h. This
result suggests the possibility that transcriptional regulation
is also involved with the decrease of WRN protein for long
term.
Mice lacking SIRT6, a member of the mammalian Sir2 fam-
ily, show genomic instability through the DNA base excision
repair pathway and lead to aging-associated degenerative phe-
notypes [28]. In addition, it has been shown that SIRT6 is sta-
bilized by nutrient deprivation and CR in cultured cells and
rats, respectively [29]. While the details of the molecular inter-
action between SIRT6 and DNA repair are not clear, it is spec-
ulated that CR can regulate the SIRT6-mediated stability of
WRN and that other sirtuins may also be implicated in this
regulation.
By considering the eﬀects of CR and the DNA repair system
on lifespan and premature aging, respectively, our ﬁndings
provide valuable clues for an understanding of the mechanism
underlying normal aging.
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